EMA Authorised: Lyrica (pregabalin) — Upjohn EESV

View source ↗

Summary

The European Medicines Agency authorised pregabalin (brand Lyrica) for epilepsy, anxiety disorders, and neuralgia, with Upjohn EESV as the marketing authorisati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Epilepsy
• Neuralgia

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Status: Authorised. Therapeutic area: Epilepsy;Anxiety Disorders;Neuralgia. MAH: Upjohn EESV. Decision date: 25/03/2026